US2010121061A1PendingUtilityA1

Compounds capable of activating cholinergic receptors

Assignee: TARGACEPT INCPriority: Jun 16, 1998Filed: Dec 8, 2009Published: May 13, 2010
Est. expiryJun 16, 2018(expired)· nominal 20-yr term from priority
A61P 43/00C07D 213/73A61P 25/22A61P 29/02A61P 25/04A61P 25/00C07D 239/26A61K 31/505C07D 213/61A61P 25/28C07D 213/65A61K 31/44C07D 213/38C07D 403/06A61P 25/18A61P 25/14
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention generally relates to nicotinic compounds, in the form of aryl substituted olefinic compounds, as well as pro-drug, N-oxide, metabolite and pharmaceutically acceptable salt forms thereof. Methods of modulating neurotransmitter release via administration of the compounds, pro-drugs, N-oxides and/or pharmaceutically acceptable salts are also disclosed.

Claims

exact text as granted — not AI-modified
1 . A method for synthesizing a compound of formula 
     
       
         
         
             
             
         
       
     
     or a pharmaceutically acceptable salt thereof, wherein
 each of A, A I , and A II  is H; 
 X is COR I ; 
 R I  is C 1-5  alkyl; 
 X I  is N; 
 m is 1; 
 n is 1; 
 each of E I , E II , E III , E IV , and E V  is H; 
 E VI  is C 1-5  alkyl; and 
 each of Z I  and Z II  individually is H or C 1-5  alkyl; 
 
     comprising coupling of a halo-substituted pyridine with an olefin containing a secondary alcohol functionality. 
   
   
       2 . The method of  claim 1 , wherein
 each of A, A I , and A II  is H;   X is COR I ;   R I  is isopropyl;   X I  is N;   m is 1;   n is 1;   each of E I , E II , E III , E IV , and E V  is H;   geometry about the depicted wavy line is E;   E VI  is methyl;   Z I  is H; and   Z II  is methyl.   
   
   
       3 . The method of  claim 2 , wherein the halo-substituted pyridine is 3-bromo-5-isopropoxypyridine. 
   
   
       4 . The method of  claim 3 , wherein the olefin containing a secondary alcohol functionality is 4-penten-2-ol. 
   
   
       5 . The method of  claim 5 , further comprising converting to a p-toluenesulfonate ester by treating with p-toluenesulfonyl chloride. 
   
   
       6 . The method of  claim 5 , further comprising treating with methylamine. 
   
   
       7 . A method for synthesizing a compound of formula 
     
       
         
         
             
             
         
       
     
     or a pharmaceutically acceptable salt thereof, wherein
 each of A, A I , and A II  is H; 
 X is COR I ; 
 R I  is C 1-5  alkyl; 
 X I  is N; 
 m is 1; 
 n is 1; 
 each of E I , E II , E III , E IV , and E V  is H; 
 E VI  is C 1-5  alkyl; and 
 each of Z I  and Z II  individually is H or C 1-5  alkyl; comprising coupling of a halo-substituted pyridine with an olefin containing a protected amine functionality. 
 
   
   
       8 . The method of  claim 7 , wherein
 each of A, A I , and A II  is H;   X is COR I ;   R I  is isopropyl;   X I  is N;   m is 1;   n is 1;   each of E I , E II , E III , E IV , and E V  is H;   geometry about the depicted wavy line is E;   E VI  is methyl;   Z I  is H; and   Z II  is methyl.   
   
   
       9 . The method of  claim 8 , wherein the halo-substituted pyridine is 3-bromo-5-isopropoxypyridine. 
   
   
       10 . The method of  claim 9 , wherein the olefin containing a protected amine functionality is N-methyl-N-(tert-butoxycarbonyl)-4-penten-2-amine.

Join the waitlist — get patent alerts

Track US2010121061A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.